78 related articles for article (PubMed ID: 8735794)
1. Review of pumps for continuous infusion of coagulation factor concentrates: what are the options?
Martinowitz U; Schulman S
Blood Coagul Fibrinolysis; 1996 Mar; 7 Suppl 1():S27-33. PubMed ID: 8735794
[TBL] [Abstract][Full Text] [Related]
2. Prophylaxis and continuous infusion for hemophilia: can we afford it?
Aledort LM; Bohn RL
Blood Coagul Fibrinolysis; 1996 Mar; 7 Suppl 1():S35-7. PubMed ID: 8735795
[TBL] [Abstract][Full Text] [Related]
3. Rationale and indications for continuous infusion of antihemophilic factor (factor VIII).
Goldsmith JC
Blood Coagul Fibrinolysis; 1996 Mar; 7 Suppl 1():S3-6. PubMed ID: 8735789
[TBL] [Abstract][Full Text] [Related]
4. Factor VIII pharmacokinetics: intermittent infusion versus continuous infusion.
Morfini M; Messori A; Longo G
Blood Coagul Fibrinolysis; 1996 Mar; 7 Suppl 1():S11-4. PubMed ID: 8735791
[TBL] [Abstract][Full Text] [Related]
5. In vitro factor VIII recovery during the delivery of ultrapure factor VIII concentrate by continuous infusion.
DiMichele DM; Lasak ME; Miller CH
Am J Hematol; 1996 Feb; 51(2):99-103. PubMed ID: 8579073
[TBL] [Abstract][Full Text] [Related]
6. Continuous infusion of coagulation factors: current opinion.
Batorova A; Martinowitz U
Curr Opin Hematol; 2006 Sep; 13(5):308-15. PubMed ID: 16888434
[TBL] [Abstract][Full Text] [Related]
7. Inhibitor development in patients with hemophilia A after continuous infusion of FVIII concentrates.
von Auer Ch; Oldenburg J; von Depka M; Escuriola-Ettinghausen C; Kurnik K; Lenk H; Scharrer I
Ann N Y Acad Sci; 2005 Jun; 1051():498-505. PubMed ID: 16126990
[TBL] [Abstract][Full Text] [Related]
8. Stability of ADVATE, Antihemophilic Factor (Recombinant) Plasma/Albumin-Free Method, during simulated continuous infusion.
Fernandez M; Yu T; Bjornson E; Luu H; Spotts G
Blood Coagul Fibrinolysis; 2006 Apr; 17(3):165-71. PubMed ID: 16575253
[TBL] [Abstract][Full Text] [Related]
9. Relationship between factor VII activity and clinical efficacy of recombinant factor VIIa given by continuous infusion to patients with factor VIII inhibitors.
Santagostino E; Morfini M; Rocino A; Baudo F; Scaraggi FA; Gringeri A
Thromb Haemost; 2001 Oct; 86(4):954-8. PubMed ID: 11686352
[TBL] [Abstract][Full Text] [Related]
10. [Recombinant factor VIIa (eptacog alfa): a new therapeutic option for patients with severe bleeding disorder due to inhibitory antibodies against a coagulation factor].
Turkstra F; Levi M; Koopman MM; Wester JP; Stoutenbeek CP; Briët E
Ned Tijdschr Geneeskd; 1998 Jun; 142(25):1464-7. PubMed ID: 9752060
[TBL] [Abstract][Full Text] [Related]
11. Family issues in continuous infusion therapy with factor VIII.
Manco-Johnson MJ
Blood Coagul Fibrinolysis; 1996 Mar; 7 Suppl 1():S21-5. PubMed ID: 8735793
[TBL] [Abstract][Full Text] [Related]
12. Continuous infusion of recombinant factor VIIa: continue or not?
Ewenstein BM
Thromb Haemost; 2001 Oct; 86(4):942-4. PubMed ID: 11686349
[No Abstract] [Full Text] [Related]
13. Continuous infusion of recombinant activated factor VII: stability in infusion pump systems.
Bonde C; Jensen MB
Blood Coagul Fibrinolysis; 1998 Mar; 9 Suppl 1():S103-5. PubMed ID: 9819038
[TBL] [Abstract][Full Text] [Related]
14. Factors affecting choice of hemostatic agent for the hemophilia patient with an inhibitor antibody.
Monahan PE; Aledort LM;
Am J Hematol; 2004 Dec; 77(4):346-50. PubMed ID: 15558804
[TBL] [Abstract][Full Text] [Related]
15. Continuous infusion of coagulation factor products.
Stachnik JM; Gabay MP
Ann Pharmacother; 2002 May; 36(5):882-91. PubMed ID: 11978168
[TBL] [Abstract][Full Text] [Related]
16. A chamber of hope for hemophilia.
Pipe SW; Kaufman RJ
Nat Biotechnol; 2000 Mar; 18(3):264-5. PubMed ID: 10700134
[No Abstract] [Full Text] [Related]
17. Design and assessment of clinical trials on continuous infusion.
Schulman S; Martinowitz U
Blood Coagul Fibrinolysis; 1996 Mar; 7 Suppl 1():S7-9. PubMed ID: 8735790
[TBL] [Abstract][Full Text] [Related]
18. [Hemophilia A with factor VIII inhibitor].
Shima M
Rinsho Ketsueki; 2003 Feb; 44(2):90-101. PubMed ID: 12692981
[No Abstract] [Full Text] [Related]
19. [Perioperative use of recombinant activated factor VII (rF VIIa) in a patient with hemophilia A having inhibitors].
Kawasaki Y; Saeki N; Kawamoto M; Yuge O; Fujii T
Masui; 2005 Aug; 54(8):926-8. PubMed ID: 16104555
[TBL] [Abstract][Full Text] [Related]
20. In vivo bypass of hemophilia A coagulation defect by factor XIIa implant.
Ton-That TT; Doron D; Pollard BS; Bacher J; Pollard HB
Nat Biotechnol; 2000 Mar; 18(3):289-95. PubMed ID: 10700143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
